SCHEMBL24425191

SCHEMBL24425191

Cc1c(F)ccc2sc(N)nc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.62
ALDH1A1 P00352 6/20 0.53
LMNA P02545 3/20 0.49
CYP3A4 P08684 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
HSD17B10 Q99714 2/20 0.44
PDPK1 O15530 1/20 0.44
PDE10A Q9Y233 1/20 0.44
MAPT P10636 3/20 0.41
RAB9A P51151 2/20 0.41
AXL P30530 1/20 0.41
GFER P55789 1/20 0.41
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
ILK Q13418 1/20 0.38
MPL P40238 1/20 0.38
GAA P10253 3/20 0.38
HTT P42858 1/20 0.38
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30829728 1.00 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1LMNACYP3A4TDP1
SCHEMBL29754543 0.81 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1LMNACYP3A4TDP1
SCHEMBL6234853 0.81 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1LMNACYP3A4TDP1
SCHEMBL30904497 0.81 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1LMNACYP3A4TDP1
SCHEMBL2748639 0.81 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1LMNACYP3A4TDP1
SCHEMBL29211380 0.79 RAB9A (0.41) SMN1; SMN2ALDH1A1LMNATDP1MAPT
SCHEMBL30829739 0.79 RAB9A (0.41) SMN1; SMN2ALDH1A1LMNATDP1MAPT
SCHEMBL31389818 0.78 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1LMNACYP3A4TDP1
SCHEMBL7936559 0.78 PDPK1 (0.58) SMN1; SMN2ALDH1A1LMNACYP3A4TDP1
SCHEMBL30829749 0.78 LMNA (0.58) SMN1; SMN2ALDH1A1LMNACYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4389751-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Kumquat Biosciences Inc. (US) 2024-06-26 EP disclosed
WO-2023215802-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. (US) 2023-11-09 WO disclosed
WO-2023215801-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. (US) 2023-11-09 WO disclosed
WO-2023172737-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. (US) 2023-09-14 WO disclosed
EP-4242207-A1 KRAS INHIBITORS FOR TREATMENT OF CANCERS Tyligand Bioscience (Shanghai) Limited (CN) 2023-09-13 EP disclosed
WO-2023141300-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF KUMQUAT BIOSCIENCES INC. (US) 2023-07-27 WO disclosed
WO-2022266015-A1 FUSED HETEROARYL COMPOUNDS USEFUL AS ANTICANCER AGENTS KUMQUAT BIOSCIENCES INC. (US) 2022-12-22 WO disclosed
CN-115232144-A Nitrogen-containing fused ring derivative, pharmaceutical composition, preparation method and application thereof 长春金赛药业有限责任公司 2022-10-25 CN disclosed
WO-2022095960-A1 KRAS INHIBITORS FOR TREATMENT OF CANCERS 泰励生物科技(上海)有限公司 2022-05-12 WO disclosed